Investment analysts at Wedbush decreased their FY2025 earnings estimates for Werewolf Therapeutics in a research note issued ...

Wedbush reissued their outperform rating on shares of Werewolf Therapeutics (NASDAQ:HOWL – Free Report) in a report issued on Wednesday morning, Marketbeat Ratings reports. They currently have a $8.00 ...

The key myth, Erica suggests, is the story of the origin of Rome: Romulus and Remus were abandoned in a forest and suckled by ...